Research

Energy balance

28.1% of eligible patients were current users of GLP-1 receptor agonists.

A notable proportion of eligible OSA patients are utilizing GLP-1 RAs, indicating potential treatment pathways.

StrongSupportsmedium confidence
There were 70 (28.1%) current GLP-1 RA users among eligible patients.
Rachel B. Kutler et al. · Otolaryngology · 2026

Why this rating

Based on the large sample size and retrospective study design.

Source

Glucagon‐Like Peptide‐1 Receptor Agonist Utilization Among Sleep Surgery Clinic Patients

Rachel B. Kutler et al. · Otolaryngology · 2026

DOI 10.1002/ohn.70231

cohort · n=384
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →